Inhibition of interleukin-1beta and prostaglandin E(2) thermogenesis by glycyl-glutamine, a pro-opiomelanocortin-derived peptide

Interleukin-1beta (IL-1beta) and other cytokines produce fever by stimulating prostaglandin E(2) (PGE(2)) synthesis in thermoregulatory regions of the preoptic area and anterior hypothalamus (POA/AH). Prostaglandin E(2) is thought to raise body temperature, at least in part, by stimulating beta-endorphin release from pro-opiomelanocortin neurons that innervate the POA/AH. In this study, we investigated whether glycyl-glutamine (beta-endorphin(30-31)), an inhibitory dipeptide synthesized from beta-endorphin post-translationally, inhibits IL-1beta and PGE(2)-induced hyperthermia. Hyperthermic sites were identified by microinjecting PGE(2) (3 fmol/1 microl) into the medial preoptic area (mPOA) of conscious, unrestrained rats. Interleukin-1beta (1 U) injection into the same PGE(2) responsive thermogenic sites in the mPOA elicited a prolonged rise in colonic temperature (T(c)) (+1.02+/-0.06 degrees C) that persisted for at least 2 h. Glycyl-glutamine (3 nmol) co-injection into the mPOA inhibited IL-1beta thermogenesis completely (T(c)=-0.18+/-0.22 degrees C). Glycyl-glutamine had no effect on body temperature when given alone to normothermic rats. Co-injection of individual amino acids, glycine and glutamine (3 nmol each amino acid), failed to influence IL-1beta-induced thermogenesis, which indicates that Gly-Gln hydrolysis does not explain its inhibitory activity. Glycyl-glutamine (3 nmol) also prevented the rise in body temperature produced by PGE(2) (PGE(2)=0.89+/-0.05 degrees C; PGE(2) plus Gly-Gln=-0.16+/-0.14 degrees C), consistent with evidence that PGE(2) mediates IL-1beta-induced fever. These findings demonstrate that Gly-Gln inhibits the thermogenic response to endogenous pyrogens.     

Antibodies to macrophage inflammatory protein-1β in preoptic area of rats fail to suppress PGE2 hyperthermia

This study determined whether macrophage inflammatory protein-1β (MIP-1β) plays a role in the hyperthermia caused by prostaglandin E₂ (PGE₂) given intracerebroventricularly (i.c.v.) in the rat. In these experiments, anti-murine MIP-1β antibody (anti-MIP-1β) was micro-injected in the anterior hypothalamic, preoptic area (AH/POA) just before i.c.v. PGE₂. The results showed that anti-MIP-1β failed to alter the PGE₂ hyperthermia. However, immunocytochemical studies revealed MIP-1β immunoreactivity detectable in both the organum vasculosum laminae terminalis (OVLT) and AH/POA in the febrile rat. These data thus demonstrate that MIP-1β is sequestered in diencephalic structures underlying thermoregulation even though it is not involved in PGE₂ hyperthermia. This dissociation supports the viewpoint that at least two distinct systems exist in the brain which underlie a febrile response: MIP-1β underlies one component whereas PGE₂ comprises the other.     

Fever evoked by macrophage inflammatory protein-1 (MIP-1) injected into preoptic or ventral septal area of rats depends on intermediary protein synthesis

Macrophage inflammatory protein-1 (MIP-1), a novel cytokine composed of α/β subunits, is released from macrophages during infection, MIP-1 injected intravenously in the rabbit or into the anterior hypothalamic, preoptic area (AH/POA) of the rat causes an intense fever, which is not blocked by prostaglandin synthesis inhibitors, ibuprofin or indomethacin, respectively. The purpose of this study was to determine the role of de novo protein synthesis on the fever evoked by MIP-1 applied to thermosensitive cells of the AH/POA. Guide cannulae were implanted bilaterally above the AH/POA or ventral septal area (VSA) and medially above the third cerebral ventricle in each of 11 male Sprague-Dawley rats. Following postoperative recovery, body temperature (T_b) was monitored by a colonic thermistor probe. The bilateral microinjection of MIP-1 in a dose of 14 pg per 0.5 μ1 into the AH/POA caused a biphasic elevation in T_b to 0.9 ± 0.2 °C within 3.0 h, and persisted for over 6.0 h. An identical injection of MIP-1 into the VSA increased T_b biphasically to 0.1 ± 0.1 °C within 1.0 h and to 0.8 ± 0.3 °C within 3.0 h. The infusion into the third ventricle of 80 μg/10 μ1 of the inhibitor of protein synthesis, anisomycin, either 10 or 30 min before the microinjection of MIP-1 into the AH/POA, attenuated significantly the rise in T_b for 1.0 to 3.0 h or 2.5 to 3.0 h, respectively. These results coincide with the earlier finding that anisomycin inhibits both endotoxin- and IL-1β-induced fevers. Further, the synthesis of a new protein factor may be required functionally for the initiation and maintenance of a fever whose mechanism of induction apparently is metabolically independent of the cyclooxygenase pathway.     

Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigs

Prostaglandin E₂ (PGE₂) is postulated to be a central mediator of fever. It is generally believed that it is produced in the preoptic area of the anterior hypothalamus (POA) because, among other evidence, its level increases both in the third ventricle and in the POA in response to pyrogens. However, lately, the question has arisen whether PGE₂ might, in fact, be formed outside of the brain substance and then penetrate it, in particular through the organum vasculosum laminae terminalis. If produced outside the brain substance, the peripheral blockade of its synthesis should prevent lipopolysaccharides (LPS)-induced fever, whereas the intracarotid infusion of PGE₂ should produce an increase in core temperature (T_c) as well as in preoptic PGE₂. To verify this hypothesis, continuous measurements of T_c and preoptic PGE₂ levels were made in conscious guinea pigs administered the PGE₂ synthase inhibitor, indomethacin (10 or 50 mg/kg, im) 30 min before S. enteritidis LPS (2 μg/kg, iv) or before PGE₂ microdialyzed into the POA (1 μg/μl at 2μl/min for 2.5 h) and during PGE₂ infused into a carotid artery (1 μg and 10 μg/μl at 2 μl/min for 1 h). LPS induced a biphasic 1.4°C fever that was consistently associated with an increase in the level of PGE₂ in the POA. Indomethacin at 10 mg/kg attenuated the course of the LPS-induced fever and prevented the associated increase in preoptic PGE₂ for 90 min after fover onset; thereafter, PGE₂ was significantly reduced by comparison with controls. Indomethacin at 50 mg/kg completely abolished both the fever and the increased levels of PGE₂ in the POA; the fever induced by PGE₂ microdialyzed into the POA was not affected by indomethacin pretreatment. The intracarotid infusion of PGE₂ produced T_c falls and no increase in preoptic PGE₂ levels. The indomethacin-induced blockade of fever and inhibition of the associated increase in preoptic PGE₂ levels further substaintiates the presumptive link between PGE₂ in the POA and fever caused by LPS. The failure of exogenous PGE₂ infusion to induce increases in T_c and preoptic PGE₂ levels excludes the possibility that PGE₂ formed outside of the brain penetrates the POA and induces fever. Thus, in guinea pigs, the PGE₂ associated with LPS-induced fever may be synthesized in the POA.     

Cyclo(Gly-Gln) inhibits the cardiorespiratory depression produced by β-endorphin and morphine

Glycyl-

Full-size image

-glutamine (Gly-Gln; β-endorphin_30–31) is an endogenous dipeptide that is synthesized through the post-translational processing of β-endorphin. Previously, we showed that Gly-Gln inhibits the hypotension and respiratory depression produced by central β-endorphin administration. In this study, we tested whether cyclo(Gly-Gln), a non-polar, cyclic Gly-Gln derivative, was similarly effective following intracerebro-ventricular (i.c.v.) or intra-arterial (i.a.) administration to pentobarbital-anesthetized rats pretreated with β-endorphin (0.5 nmol i.c.v.). Intracerebroventricular cyclo(Gly-Gln) (0.3, 0.6 or 1.0 nmol) injection produced a dose-dependent inhibition of β-endorphin-induced hypotension, but not bradycardia, with a potency similar to that of Gly-Gln. Cyclo(Gly-Gln) (5 mg/kg) was also effective following i.a. injection and significantly attenuated the fall in arterial pressure elicited by i.c.v. β-endorphin, consistent with evidence that cyclic dipeptides permeate the blood–brain barrier; i.a. Gly-Gln was ineffective. Intra-arterial cyclo(Gly-Gln) (5 mg/kg) and i.c.v. Gly-Gln (10 nmol) also attenuated the hypotension and respiratory depression induced by morphine (50 or 100 nmol i.c.v.). Cyclo(Gly-Gln) (0.5, 5.0 or 50.0 mg/kg i.a.) had no effect on arterial pressure or heart rate when given alone. These findings indicate that cyclo(Gly-Gln) is a biologically active peptide capable of reversing the cardiorespiratory depression produced by β-endorphin or morphine.     

Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats

The systemic administration of lipopolysaccharide (LPS), an experimental model of systemic bacterial infection is known to modulate nociception. It increases the prostaglandin E₂ (PGE₂) levels in the preoptic area of the hypothalamus (POA) and the microinjection of PGE₂ into the POA and the neighboring basal forebrain induces hyperalgesia. We, therefore, hypothesized that the PGE₂ synthesized in these regions mediates intravenous (i.v.) LPS-induced hyperalgesia. To test this hypothesis, we microinjected cyclooxygenase (COX) inhibitors into several sites in the rat hypothalamus and observed their effects on the LPS (0.1–100 μg/kg, i.v.)-induced changes in nociceptive behavior as assessed by a plantar test. LPS (10 and 100 μg/kg, i.v.) reduced the paw-withdrawal latency at 90 min and 45–60 min after injection, respectively, both thus indicating a hyperalgesic effect. This hyperalgesia was observed only in the period before the development of fever which started 120–135 min after the LPS injection. The LPS (100 μg/kg, i.v.)-induced hyperalgesia was completely abolished by pretreatment with the microinjection of diclofenac (an inhibitor of COX-1 and 2) at 1.0 ng into the bilateral POA. Furthermore, it was also blocked by the microinjection of NS-398 (a selective COX-2 inhibitor) at 1.0 ng into the bilateral POA and the horizontal limb of the diagonal band of Broca (DBB), but not the lateral hypothalamic area, the paraventricular hypothalamic nucleus, and the ventromedial hypothalamic nucleus. These findings suggest that LPS (i.v.)-induced hyperalgesia is mediated predominantly through a COX-2 induced prostanoids in the POA and the DBB in rats.     

Cytokines and Thermoregulation: Interleukin-9 Injected in preoptic area fails to evoke fever in rats

A number of the members of the family of cytokines including IL-1, IL-2, IL-6, and IL-11 act directly in the brain to induce a febrile response in the rat and other species. The purpose of this study was to examine the effect of interleukin-9 (IL9) when this cytokine is applied directly to the thermosensitive and pyrogen reactive region of the anterior hypothalamic, preoptic area (AH/POA). In male Sprague-Dawley rats, guide cannulae for microinjection into the AH/POA were implanted stereotaxically, and radio transmitters for monitoring body temperature (T_b) were placed intraperitoneally. Following postoperative recovery, recombinant murine macrophage inflammatory protein (MIP)-1β was microinjected in the AH/POA of each rat in a dose of 28 pg/1μl to identify pyrogen reactive sites in the AH/POA. Then recombinant human IL-9 was suspended in pyrogen-free CSF vehicle and microinjected in the same sites in concentrations of 2.4, 24, and 240 U/μl. In contrast to the pyrexic action of MIP-1β, IL-9 failed to elicit a significant alteration in the T_b of the rats at any of the doses tested. IL-9 was also without effect on the intakes of either water or food. These results demonstrate that IL-9 applied to the region of the diencephalon in which other cytokines act to evoke fever may not play a direct role in the thermogenic component underlying the acute phase response. However, as demonstrated in several different cell systems, IL-9 may require a cofactor related to pyrogen for a febrile response to develop.     

NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2

Epidemiological studies have shown that steroidal as well as non-steroidal anti-inflammatory drugs lower the risk of developing Alzheimer's Disease (AD). A suppressive effect of these anti-inflammatory drugs on local inflammatory events in AD brains has been suggested, however the mechanisms responsible are still unknown. In this study we investigated at cellular level the influence of two anti-inflammatory drugs—dexamethasone and indomethacin—and an experimental specific cyclooxygenase-2 inhibitor, BF389, on the production of the pro-inflammatory cytokine IL-6 and the inflammatory mediator PGE₂ by human astrocytes. Two human post-mortem astrocyte cultures (A157 and A295) and astroglioma cell lines (U251 and U373 MG) were found to secrete considerable amounts of IL-6 upon stimulation with IL-1β. The glucocorticoid dexamethasone inhibited the IL-1β-activated release of IL-6 from the postmortem astrocyte cultures A157 and A295 and from the astroglioma cell lines. The non-specific cyclooxygenase inhibitor indomethacin and BF389 only suppressed the IL-6 release by post-mortem astrocyte culture A157. This post-mortem astrocyte culture was found to produce large amounts of PGE₂ upon stimulation with IL-1β, whereas in the supernatants of the postmortem astrocyte culture A295 and the astroglioma cell lines, low PGE₂ concentrations were detected. Addition of exogenous PGE₂ prevented the inhibitory effect of indomethacin and BF389 on the IL-1β-activated IL-6 release from A157 astrocytes and largely potentiated the IL-1-induced release of IL-6 from all astrocytes/astroglioma cells tested. Dexamethasone also inhibited the PGE₂ release from the astrocytes and astroglioma cells, however the inhibitory effect of dexamethasone on the IL-1β-activated IL-6 release could not be prevented by the addition of PGE₂. The observed reduction of IL-6 and/or PGE₂ from astrocytes may be involved in the mechanism underlying the beneficial effects of these drugs in AD.     

Prostaglandin E2 may induce hyperthermia through EP1 receptor in the anterior wall of the third ventricle and neighboring preoptic regions

We have previously reported that intracerebroventricular injection of prostaglandin E₂ (PGE₂) induces hyperthermia possibly through EP₁ receptors in the rat. In the present study, to determine the sites in the brain where PGE₂ induces hyperthermia through EP₁ receptors, we microinjected an EP₁ receptor agonist, 17-phenyl-ω-trinor PGE₂ (17-Ph-PGE₂, 100 ng) into different sites in the rat brain and observed the colonic temperature (T_co) for 2 h in a 23±1°C environment. Responsive sites where 17-Ph-PGE₂ (100 ng) produced a rise in the T_co of more than 1.1°C within 60 min after injection were found in the medial preoptic area, the subchiasmatic portion of the median preoptic nucleus, the anterior wall of the third ventricle (A3V) and the ventral portion of the diagonal band of Broca. Among these sites, the A3V was the most responsive. In contrast, microinjection of neither butaprost (an EP₂ agonist, 100 ng) nor M&B28767 (an EP₃ agonist, 100 ng) into these four sites had any effect on the T_co. Intracerebroventricular pretreatment with SC-19220 (an EP₁ antagonist, 100 μg) inhibited the rise in the T_co which was induced by microinjection of PGE₂ (50 ng) into the A3V. These results thus suggest that PGE₂ induces hyperthermia by stimulating EP₁ receptors in the A3V and the neighboring preoptic region.     

N-Monomethyl-l-arginine co-injection attenuates the thermogenic and hyperthermic effects of E2 prostaglandin microinjection into the anterior hypothalamic preoptic area in rats

Prostaglandin E₂ (PGE₂) microinjection (25 ng, 250 nl) into the preoptic area of the anterior hypothalamus (POAH) stimulated heat production in brown adipose tissue (BAT) and increased core temperature in urethane-anesthetized rats. These thermogenic and hyperthermic effects were attenuated by co-injection of N^G-monomethyl-l-arginine (NMMA, 25 μg), a competitive inhibitor of nitric oxide (NO) production froml-arginine. Inclusion ofl-arginine (50 μg), though notd-arginine (50μg) reversed the inhibitory effect of NMMA (25μg) on intra-POAH PGE₂-induced increases in interscapular BAT (IBAT) and core temperatures. Intra-POAH injection of NMMA (25 μg) orl-arginine (50 μg) alone had no effect on IBAT and core temperatures. The results suggest that the effect on thermoregulation induced by action of PGE₂ in the POAH is modulated by a locall-arginine-dependent and NMMA-sensitive NO-generating system.     

Biphasic modulation in the trigeminal nociceptive neuronal responses by the intracerebroventricular prostaglandin E2 may be mediated through different EP receptors subtypes in rats

To determine which prostaglandin E₂ (PGE₂) receptor subtypes are involved in the brain-derived PGE₂-induced changes in nociception, we injected synthetic EP₁, EP₂ and EP₃ receptor agonists (0.01 fmol to 10 nmol) into the lateral cerebroventricle (LCV) of urethane-anesthetized rats and observed the changes in the responses of the wide dynamic range (WDR) neurons in the trigeminal nucleus caudalis to noxious pinching of facial skin. The enhancement and suppression of the nociceptive responses of the WDR neurons were observed after the LCV injection of MB28767 (an EP₃ receptor agonist) at a low dose range (1–100 fmol) and 17-phenyl-ω-trinor PGE₂ (an EP₁ receptor agonist) at high doses (1–10 nmol), respectively. Furthermore, the suppression of nociceptive neuronal responses after the LCV injection of PGE₂ (1 nmol) was completely blocked by SC19220 (an EP₁ receptor antagonist, 300 nmol). On the other hand, butaprost (an EP₂ receptor agonist) at any doses tested (0.1 fmol to 1 nmol) had no effect on the nociceptive responses. The LCV injection of MB28767 (10 fmol) and 17-phenyl-ω-trinor PGE₂ (1 nmol), which respectively enhanced and suppressed the nociceptive neuronal responses, did not affect the responses of the low threshold mechanoreceptive neurons to innocuous tactile stimuli. These results provide electrophysiological evidence that brain-derived PGE₂ induces mechanical hyperalgesia and hypoalgesia through EP₃ and EP₁ receptors, respectively, in the rat.     

Effect of edta and PGE1 on β-thromboglobulin liberation from platelets

The aim of this study was to evaluate the effect of PGE₁ and EDTA on liberation of β-thromboglobulin (βTG) from platelets in vitro. Liberation of BTG was followed in citrated blood at room temperature for 120 minutes after venesection. PGE₁ reduced βTG liberation, and maximal inhibition was attained by concentrations greater than 2 × 10⁻⁶M. EDTA induced the efflux of βTG. This EDTA-induced efflux was delayed but not prevented by PGE₁ and by citrate; it was not found at 0–4°C. Therefore the use of EDTA to prevent βTG liberation during sampling for in vitro or in vivo studies depends heavily on modifying factors such as PGE₁ and low temperature, and on the time taken to process samples. Its effectiveness must be in some doubt where the platelets may be sufficiently stimulated to overcome these modifying influences, or where handling of samples is less than optimal.     

Relationship of interleukin-1β and β2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type

We studied interleukin-1β (IL-1β), β₂-microglobulin (β₂-m, β-endorphin, substance P, neuropeptide Y and somatostatin concentrations in the cerebrospinal fluid of 13 patients with dementia of the Alzheimer type (DAT), 13 patients with multi-infarct dementia (MID) and 15 age-matched control subjects. Substance P was significantly lower in DAT than in controls (P < 0.05), as well as somatostatin in DAT as compared to both controls (P < 0.01) and MID (P < 0.05), whereas β₂-m was higher in DAT than in controls (P < 0.01). Neuropeptide Y, β-endorphin and IL-1β showed similar concentrations in the three groups studied. A significantly positive correlation was observed between IL-1β and substance P (r = 0.79, P < 0.01) and somtostatin (r = 0.75, P < 0.05) in DAT, which was not observed in MID. In addition, β₂-m showed a negative correlation with IL-1β (r = −0.73, P < 0.05) in DAT, and age correlated negatively with IL-1β in controls and MID, but positively in DAT. Therefore, these results support the idea that an altered relationship may exist in Alzheimer's disease between the nervous and immune system.     

Reduced thermal sensitivity in the rabbit by β-endorphin injection into the preoptic/anterior hypothalamus

Male New Zealand White rabbits,Oryctolagus cuniculus, were stereotaxically implanted with a guide tube above the preoptic/anterior hypothalamus (PO/AH) for the injection of β-endorphin (β-E) or saline at ambient temperatures of 20 and 25 °C. Ear skin and PO/AH temperatures were recorded in loosely restrained control and β-E-pretreated rabbits while radiant heat was applied to the dorsal skin. Without β-E administration the ear skin temperature (T_ear) underwent a rapid increase during back heating. Following β-E administration there was a marked vasoconstriction along with a large reduction in responsiveness of ear skin temperature to radiant 3eat. The time to respond to radiant heat for β-E-pretreated rabbits was significantly longer than that for control rabbits. In control animals, the increase in T_ear in response to radiant heat exposure dependend upon the initial ear temperatures. However, in β-E-pretreated rabbits vasodilatation response to radiant heat exposure was nearly the same regardless of the initial T_ear. These data suggest that there is a significant reduction in passage of temperature information from cutaneous thermal receptors to the PO/AH in β-E-pretreated animals and that β-E-induced reduction in sensitivity of the vasomotor system to radiant heat may account for the effectiveness of this opioid peptide to promote hyperthermia in the rabbit.     

Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes

Here we compared the effects of cortistatin and somatostatin on the production of prostanoids from primary cultures of rat cortical microglia and astrocytes. We found that both cortistatin and somatostatin do not modify basal PGE₂ release from cultured astrocytes in 24-h experiments. Somatostatin further enhanced the increase in PGE₂ release induced by IL-1β, whereas cortistatin inhibited such increase. Experiments on microglia showed that somatostatin has no effect on basal and IL-1β-stimulated PGE₂ release, whereas cortistatin reduced baseline prostanoids production and abolished stimulation elicited by IL-1β. The latter effect was associated to the inhibition of COX-2 gene over-expression induced by the cytokine.     

The involvement of the sympathetic nervous system in the centrogenic pressor and tachycardiac effects of prostaglandins E2 and F2α in anaesthetised cats

The intracerebroventricular (i.c.v.) administration of prostaglandin E₂ (PGE₂, 1 μg) and prostaglandin F_2α (PGF_2α, 10 μg) produced prolonged pressor and tachycardiac responses in chloralose-anaesthetised cats. Phenoxybenzamine-pretreatment completely prevented the pressor response without altering the tachycardiac response, whereas propranolol intervention completely inhibited the tachycardiac response and also attenuated the pressor response. The pretreatment with pentolinium completely antagonised both the pressor and tachycardiac responses to i.c.v. PGE₂ and PGF_2α. The results suggest that the centrally administered PGE₂ and PGF_2α augment sympathetic outflow to the heart and vascular system and thereby cause excitatory cardiovascular responses in anaesthetised cats.     

Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs

It is generally believed that fever is mediated by certain cytokines produced by immune cells activated by exogenous pyrogens, e.g., lipopolysaccharides (LPS), released into the circulation and transported to the brain. There, the cytokines are thought to stimulate prostaglandin (PG) E₂ production within the organum vasculosum laminae terminalis region. PGE, then may act as a febrigenic mediator locally or in the surrounding preoptic area (POA). However, whereas the increases in preoptic PGE₂ and body (core) temperature (T_c) following the intravenous (i.0 administration of LPS correlate temporally, cytokine levels in blood lag both these increases. From recent data in the literature, we have conjectured that a possible, alternative communication pathway between the i.v. LPS-activated immune system and brain PGE₂ may be provided by the vagi. To test this possibility, we measured the levels of PGE₂ in the extracellular fluid of the POA (collected by microdialysis) of conscious, subdiaphragmatically vagotomized or sham-operated guinea pigs following LPS administration (2 μg/kg; i.v.); controls received pyrogen-free saline (PFS). The effluents from the microdialysis probes were collected over 30-min periods throughout the experiments and the samples analyzed by radioimmunoassay; (T_c) was monitored continuously using thermocouples inserted 5 cm into the colon. LPS induced a biphasic fall in T_c and failed to increase preoptic PGE₂ levels in the vagotomized guinea pigs (n = 10), whereas in their sham-operated controls (n = 10) it induced increases in both preoptic PGE₂ and (T_c) within 15 min after its injection; PFS (n = 13) had no effect on either variable. We postulate that peripheral immune cell-derived signals may be transmitted via the vagi to the medulla. From other data, we suggest further that they may be conveyed from here via the ventral noradrenergic bundle to the POA region, where the released norepinephrine induces the local synthesis of PGE₂ and, hence, fever onset.     

Brain cholecystokinin and β-endorphin systems may antagonistically interact to regulate tissue DNA synthesis in rat pups

Previously, we have shown that intracisternal (i.c.) administration of β-endorphin suppresses brain and liver DNA synthesis in rat pups. This finding is consistent with the view that endogeneous CNS β-endorphin plays an important role in controlling postnatal growth. Recent evidence suggests that brain CCK₈, the sulfated carboxyterminal octapeptide fragment of cholecystokinin, may function physiologically as an endogenous opioid antagonist. We now report that CCK₈ injected i.c. together with β-endorphin effectively prevented β-endorphin from inhibiting brain and liver DNA synthesis in 10-day-old rats. CCK₈ blocked the liver DNA effect of β-endorphin via actions within the brain, as subcutaneous administration of CCK₈ was ineffective. In contrast to CCK₈, i.c. administration of CCK_8U (the unsulfated form of CCK₈) together with β-endorphin did not prevent β-endorphin from inhibiting liver DNA synthesis, and only slightly reversed the brain DNA effect.The results obtained support a role for endogenous brain CCK₈ in the modulation of tissue DNA responses to CNS β-endorphin and possibly to other endogenous opioids. If so, interference with brain CCK function could disrupt tissue growth. Thus, normal mammalian development may require a close functional interaction between the cholecystokinin and β-endorphin systems in the brain.     

Prostaglandin E2 mediates the stimulatory effect of methoxamine on in vivo luteinizing hormone-releasing hormone (LH-RH) release in the ovariectomized female rhesus monkey

Previously, we found that noradrenergic input throughα₁-receptors modulates pulsatile release of luteinizing hormone-releasing hormone (LH-RH) in ovariectomized rhesus monkeys in the absence of estrogen. In the present study, the role of prostaglandin E₂ (PGE₂) in mediating α-adrenergic stimulation of LH-RH release is investigated. In the first experiment the effects of theα₁-adrenergic agonists methoxamine (MTX) on LH-RH and PGE₂ release were examined. Push-pull perfusion of the stalk-median eminence (S-ME) was performed in conscious, ovariectomized monkeys, and perfusate samples were collected on ice. MTX (10⁻⁵ M) was infused into the S-ME through the push cannula for 10 min at 90-min intervals, and LH-RH and PGE₂ in aliquots of the same perfusate samples were measured by radioimmunoassay. Infusion of MTX significantly stimulated LH-RH release (n = 12; P < 0.01) and PGE₂ release (P < 0.05). In the second experiment, the effect of PGE₂ infusion on LH-RH release was tested. PGE₂ (10⁻⁷ M) was infused using the same protocol as above, and LH-RH was measured in the perfusates. Infusion of PGE₂ through the push cannula significantly stimulated LH-RH release (n = 23; P < 0.05). These results suggest that the stimulatory effect of MTX on LH-RH release is at least partly mediated by PGE₂, since MTX stimulated not only LH-RH but also PGE₂ release, and since PGE₂ itself stimulated LH-RH release. Therefore, PGE₂ may be an important endogenous mediator ofα₁-adrenergic input stimulating pulsatile PH-RH release. Moreover, the stimulatory effects of MTX and PGE₂ can be observed in the absence of estrogen in the rhesus monkey, unlike in rhodents. Our results also demonstrate the usefulness of the push-pull perfusion technique for studies of cellular mechanisms in neuroendocrine research.     

Characteristics of the β1- and β2-adrenergic-sensitive adenylate cyclases in glial cell primary cultures and their comparison with β2-adrenergic-sensitive adenylate cyclase of meningeal cells

The agonist specificity pattern of the β-adrenergic adenylate cyclase in glial primary cultures was not typical of either β₁- or β₂-adrenergic receptors. The dose-response curves for adrenaline did not correspond to simple mass action kinetics and their computer analysis suggests the presence of both β₁- and β₂-adrenergic-sensitive adenylate cyclase (58 ± 17% and 42 ± 17% respectively).Similar properties of β₁- and β₂-adrenergic-sensitive adenylate cyclases were found by computer analysis of the dose-response curves for isoprenaline in the presence of a constant concentration of practolol (a selective β₁ antagonist) ( 55 ± 10% and 45 ± 10% of β₁- and β₂-sensitive adenylate cyclase respectively).The curves for displacement of [³H]dihydroalprenolol by practolol confirm these results.For purpose of comparison, the β-adrenergic receptors of meningeal cells in cultures were subjected to similar analysis. The results clearly showed that these cells exclusively contained β₂-adrenergic receptors.